Marcel R.M. van den Brink

Medical Oncologist

Head, Division of Hematologic Oncology; Alan N. Houghton Chair

van den Brink

About Me

My expertise is in allogeneic (donor-provided) blood stem cell transplantation for adult cancer patients. In my laboratory, I investigate the immunological aspects of bone marrow transplantation. My major projects include strategies to enhance post-transplant immune reconstitution; the role of T cells in graft-versus-host-disease, a potentially fatal complication of bone marrow transplants in which immune cells from the donor attack the patient’s tissues; and graft-versus-tumor activity, a beneficial side effect of bone marrow transplants in which donor immune cells attack the patient’s tumor cells.

Read more

As a physician-scientist, it is my goal to translate the findings of my laboratory into new therapies that can be evaluated in clinical trials, which could improve the outcome for our transplant patients. Please see the link below for more information about my research activities at the Sloan Kettering Institute.

  • Clinical Expertise: Allogeneic Bone Marrow Transplantation
  • Languages Spoken: English
  • Education: MD, PhD, Leiden University (Netherlands)
  • Residencies: Duke University Medical Center
  • Fellowships: Beth Israel Deaconess Medical Center
  • Board Certifications: Medical Oncology

My Research

View my lab

See Marcel R.M. van den Brink’s laboratory
research at Memorial Sloan Kettering.


Visit PubMed for a full listing of Marcel R.M. van den Brink’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more